Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

381 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Laparoscopic surgery in the treatment of stage I adult granulosa cells tumors of the ovary: Results from the MITO-9 study.
Bergamini A, Ferrandina G, Candiani M, Cormio G, Giorda G, Lauria R, Perrone AM, Scarfone G, Breda E, Savarese A, Frigerio L, Gadducci A, Mascilini F, Maneschi F, Cassani C, Marchetti C, Cecere SC, Biglia N, De Giorgi U, Raspagliesi F, Lorusso D, Mangili G. Bergamini A, et al. Among authors: gadducci a. Eur J Surg Oncol. 2018 Jun;44(6):766-770. doi: 10.1016/j.ejso.2018.03.001. Epub 2018 Mar 10. Eur J Surg Oncol. 2018. PMID: 29576462
Long-term follow-up is crucial after treatment for granulosa cell tumours of the ovary.
Mangili G, Ottolina J, Gadducci A, Giorda G, Breda E, Savarese A, Candiani M, Frigerio L, Scarfone G, Pignata S, Rossi R, Marinaccio M, Lorusso D. Mangili G, et al. Among authors: gadducci a. Br J Cancer. 2013 Jul 9;109(1):29-34. doi: 10.1038/bjc.2013.241. Epub 2013 Jun 11. Br J Cancer. 2013. PMID: 23756859 Free PMC article.
Adjuvant chemotherapy does not improve disease-free survival in FIGO stage IC ovarian granulosa cell tumors: The MITO-9 study.
Mangili G, Ottolina J, Cormio G, Loizzi V, De Iaco P, Pellegrini DA, Candiani M, Giorda G, Scarfone G, Cecere SC, Frigerio L, Gadducci A, Marchetti C, Ferrandina G. Mangili G, et al. Among authors: gadducci a. Gynecol Oncol. 2016 Nov;143(2):276-280. doi: 10.1016/j.ygyno.2016.08.316. Epub 2016 Sep 3. Gynecol Oncol. 2016. PMID: 27597380
Carboplatin-based doublet plus bevacizumab beyond progression versus carboplatin-based doublet alone in patients with platinum-sensitive ovarian cancer: a randomised, phase 3 trial.
Pignata S, Lorusso D, Joly F, Gallo C, Colombo N, Sessa C, Bamias A, Salutari V, Selle F, Frezzini S, De Giorgi U, Pautier P, Bologna A, Orditura M, Dubot C, Gadducci A, Mammoliti S, Ray-Coquard I, Zafarana E, Breda E, Favier L, Ardizzoia A, Cinieri S, Largillier R, Sambataro D, Guardiola E, Lauria R, Pisano C, Raspagliesi F, Scambia G, Daniele G, Perrone F; MITO16b/MANGO–OV2/ENGOT–ov17 Investigators. Pignata S, et al. Among authors: gadducci a. Lancet Oncol. 2021 Feb;22(2):267-276. doi: 10.1016/S1470-2045(20)30637-9. Lancet Oncol. 2021. PMID: 33539744 Clinical Trial.
Phase III multicenter randomized trial of amifostine as cytoprotectant in first-line chemotherapy in ovarian cancer patients.
Lorusso D, Ferrandina G, Greggi S, Gadducci A, Pignata S, Tateo S, Biamonte R, Manzione L, Di Vagno G, Ferrau' F, Scambia G; Multicenter Italian Trials in Ovarian Cancer invesitgators. Lorusso D, et al. Among authors: gadducci a. Ann Oncol. 2003 Jul;14(7):1086-93. doi: 10.1093/annonc/mdg301. Ann Oncol. 2003. PMID: 12853351 Free article. Clinical Trial.
381 results